Hispanopedia WikiFadrozole (INNTooltip International Nonproprietary Name), sold under the brand name Afema (by Novartis), is a selective, nonsteroidalaromatase inhibitor which is or has been used in Japan for the treatment of breast cancer.[1][2]
References
- ^Browne LJ, Gude C, Rodriguez H, Steele RE, Bhatnager A (February 1991). "Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease". J. Med. Chem. 34 (2): 725–36. doi:10.1021/jm00106a038. PMID 1825337.
- ^Raats JI, Falkson G, Falkson HC (January 1992). "A study of fadrozole, a new aromatase inhibitor, in postmenopausal women with advanced metastatic breast cancer". J. Clin. Oncol. 10 (1): 111–6. doi:10.1200/jco.1992.10.1.111. PMID 1530798.
{{cite journal}}: CS1 maint: deprecated archival service (link)
Categories:
- Drugs not assigned an ATC code
- 11β-Hydroxylase inhibitors
- 27-Hydroxylase inhibitors
- Aromatase inhibitors
- Hormonal antineoplastic drugs
- Imidazopyridines
- Nitriles
- Antineoplastic and immunomodulating drug stubs